## Abstract A set of growth arrest‐specific (gas) genes negatively regulated by serum has been identified. To define the role of gas genes in a model of cell proliferation in vivo we analyzed the expression of one of these genes (gas‐6) during liver regeneration after partial hepatectomy (PH). We f
Estrogen-regulated expression of a growth arrest specific gene (gas-1) in rat uterus
✍ Scribed by Marina Ferrero; Gaetano Cairo
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 405 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1065-6995
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
gas‐1 belongs to a family of growth arrest specific genes negatively regulated after growth induction of arrested cells. We report the expression of gas‐1 in an in vivo system of cell proliferation. gas‐1 mRNA accumulates progressively in the uterus of ovariectomized rats with a peak at three weeks after surgery. After estrogen treatment gas‐1 mRNA levels decrease within two hours, at a time when c‐myc expression is greatly increased, and return to pretreatment levels at 48 hours. Treatment with cycloheximide does not prevent estrogen‐induced down‐regulation of gas‐1 mRNA levels. The present results show that: i) estrogen affects the uterine growth state by regulating the expression of both positively and negatively acting genes, ii) gas‐1 expression is controlled by cellular growth state also in vivo.
📜 SIMILAR VOLUMES
The GAS1 gene product induces growth arrest through a p53-dependent mechanism. To investigate whether GAS1 is a tumor suppressor gene, we transfected GAS1-negative human tumor cells with GAS1 plasmids and analyzed growth characteristics of stable transfectants. When a constitutively expressing GAS1
Neural tube defects (NTDs) are among the most common congenital malformations, affecting approximately 1 per 1,000 liveborn infants in the United States . Maternal exposure to hyperthermia, either through recreational sources or due to an infectious agent, is thought to account for approximately 10%
## Abstract Vascular smooth muscle cell (VSMC) hyperplasia is responsible for the failure of 15–30% of vascular surgical procedures such as coronary artery bypass grafts and angioplasties. We and others have shown that heparin suppresses VSMC proliferation in vivo and in cell culture. We hypothesiz